Dr. Justin Ripper is Head of Medicinal Chemistry at Gertrude Biomedical working towards the development of small molecules, that target SOX18, with the potential to become drugs. Justin has over 25 years’ experience as a Medicinal Chemist in Drug Discovery, working in senior roles with companies such as SYNthesis Med. Chem., Bionomics Ltd and the AstraZeneca funded, Natural Product Drug Discovery Program, at Griffith University. He has worked in the field of Oncology for the past 15 years and is keenly motivated by working with such a multidisciplinary team at Gertrude. He is determined to make a difference to patients suffering from disease.